-
COSA Exercise Guidelines: What is the value of implementation?
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of HIV Prevention and Treatment Portfolios in US Prison Settings
Mar 10, 2025, 14:00 PM -
The Impact of Research Sessions on Pharmacy Students’ Perceived Understanding in Research Design and Methodology
Mar 10, 2025, 14:00 PM -
Real-World Healthcare Resource Utilization and Economic Burden Associated With Progressive Pulmonary Fibrosis in Commercially Insured and Medicare Advantage Populations in the United States
Mar 10, 2025, 14:00 PM -
Medicare Spending on Orphan Drugs With Single and Multiple Rare Disease Indications
Mar 10, 2025, 14:00 PM -
Real-Time Technology Adoption: Assessing Early Real-World Trends in Renal Denervation Therapy Following Initial Device Approval
Mar 10, 2025, 14:00 PM -
Economic Burden of Non-Pharmacological Treatment in Amyotrophic Lateral Sclerosis in Brazil's Public Healthcare System: A 2022 Real World Cost Analysis
Mar 10, 2025, 14:00 PM -
A Cost Minimization and Budget Impact Analysis of an Eculizumab Biosimilar, ABP 959, From the Spanish Healthcare Perspective
Mar 10, 2025, 14:00 PM -
Out-of-Pocket Health Care Spending Among Medicare Beneficiaries Before and During the COVID-19 Pandemic
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization of Adult Patients with Obesity Before vs. After GLP-1 Treatment in the United States Elective Outpatient Setting
Mar 10, 2025, 14:00 PM -
Race, Social Determinants of Health (SDoH), and Stage at Breast Cancer Diagnosis in Electronic Health Records (EHR) Data
Mar 10, 2025, 14:00 PM -
Participation in a Patient Support Program is Associated With Improved Access to Efgartigimod Treatment for Generalized Myasthenia Gravis in Patients Facing Social Determinants of Health (SDOH) Challenges
Mar 10, 2025, 14:00 PM -
Impact of Newborn Screening for Duchenne Muscular Dystrophy: A Model-Based Analysis
Mar 10, 2025, 14:00 PM -
How HTA Should Consider the Global Value of Health Products to Support Public Decision?
Mar 10, 2025, 14:00 PM -
Utilization and Impact of GLP-1s: Patient-Reported Healthcare Resource Utilization and Costs in Patients With Type 2 Diabetes
Mar 10, 2025, 14:00 PM -
Understanding the Caregiver Experience Through an Exploration of the Literature
Mar 10, 2025, 14:00 PM -
Transforming Global Value Dossier (GVD) Drafting: Creation with a Generative Artificial Intelligence (Gen AI)-Driven Coauthoring Accelerator
Mar 10, 2025, 14:00 PM -
Real-World Subcutaneous Monoclonal Antibody Use Trends for Oncology in the US
Mar 10, 2025, 14:00 PM -
Real-World Use of Biologics in the Treatment of Psoriasis and Ankylosing Spondylitis in China: The Case of Secukinumab
Mar 10, 2025, 14:00 PM -
Hemoglobin Levels and Social Determinants of Health as Risk-factors of End-Organ Damage in Sickle Cell Disease: A Retrospective Analysis
Mar 10, 2025, 14:00 PM
